DCPH — Deciphera Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Deciphera Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	580	552	286	324	306
Net Total Accounts Receivable
Net Total Receivables	—	13.9	20.6	22.4	32
Total Inventory
Prepaid Expenses
Total Current Assets	593	584	339	393	381
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	27.5	45.9	45.4	43.3	37.5
Long Term Investments
Other Long Term Assets
Total Assets	622	642	429	454	474
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	60	70	96.8	86.5	100
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	75.9	98.8	125	112	123
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	546	544	305	342	351
Total Liabilities & Shareholders' Equity	622	642	429	454	474
Total Common Shares Outstanding